Total Payments
$36,071
2024 Payments
$18,583
Companies
37
Transactions
576
Medicare Patients
1,069
Medicare Billing
$128,186
Payment Breakdown by Category
Other$28,050 (77.8%)
Food & Beverage$7,964 (22.1%)
Education$56.94 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $28,050 | 20 | 77.8% |
| Food and Beverage | $7,964 | 553 | 22.1% |
| Education | $56.94 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $30,500 | 246 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $835.94 | 55 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $666.92 | 31 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $387.75 | 22 | $0 (2024) |
| Lundbeck LLC | $371.15 | 24 | $0 (2024) |
| Novo Nordisk Inc | $357.70 | 24 | $0 (2023) |
| Alkermes, Inc. | $335.19 | 18 | $0 (2024) |
| Abbott Laboratories | $333.19 | 23 | $0 (2023) |
| Corium, LLC | $270.14 | 15 | $0 (2024) |
| Lilly USA, LLC | $228.05 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18,583 | 98 | ABBVIE INC. ($17,491) |
| 2023 | $13,784 | 175 | ABBVIE INC. ($11,560) |
| 2022 | $1,633 | 147 | ABBVIE INC. ($496.06) |
| 2021 | $2,072 | 156 | AbbVie Inc. ($952.64) |
All Payment Transactions
576 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.46 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: CNS | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.71 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/15/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: NEUROSCIENCE | ||||||
| 10/08/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: NEUROSCIENCE | ||||||
| 09/25/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.91 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: NEUROSCIENCE | ||||||
| 09/07/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: CNS | ||||||
| 09/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,925.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: NEUROSCIENCE | ||||||
| 08/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 08/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,375.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: NEUROSCIENCE | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 178 | 439 | $117,097 | $30,291 |
| 2022 | 5 | 172 | 486 | $121,780 | $32,963 |
| 2021 | 8 | 316 | 757 | $116,346 | $34,445 |
| 2020 | 10 | 403 | 986 | $136,872 | $30,487 |
Total Patients
1,069
Total Services
2,668
Medicare Billing
$128,186
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 393 | $101,502 | $26,009 | 25.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 24 | 24 | $11,250 | $3,003 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 11 | 11 | $3,861 | $1,230 | 31.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 11 | 11 | $484.00 | $47.85 | 9.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 411 | $105,936 | $29,089 | 27.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $5,400 | $1,490 | 27.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 28 | $4,900 | $1,232 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 12 | 14 | $4,914 | $1,106 | 22.5% |
| 81003 | Automated urinalysis test | Office | 2022 | 14 | 21 | $630.00 | $46.42 | 7.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 150 | 325 | $84,175 | $22,666 | 26.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 63 | 133 | $23,275 | $7,667 | 32.9% |
| 87631 | Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets | Office | 2021 | 19 | 21 | $4,431 | $2,995 | 67.6% |
| 71046 | X-ray of chest, 2 views | Office | 2021 | 14 | 19 | $1,349 | $369.76 | 27.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 18 | 18 | $774.00 | $369.54 | 47.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 18 | 18 | $1,152 | $306.18 | 26.6% |
| 81003 | Automated urinalysis test | Office | 2021 | 18 | 23 | $690.00 | $51.75 | 7.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 16 | 200 | $500.00 | $19.13 | 3.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 144 | 348 | $90,132 | $19,700 | 21.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 89 | 163 | $28,525 | $6,678 | 23.4% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 14 | 14 | $5,572 | $1,163 | 20.9% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 31 | 35 | $3,675 | $902.76 | 24.6% |
| 71046 | X-ray of chest, 2 views | Office | 2020 | 22 | 35 | $2,485 | $711.66 | 28.6% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 12 | 12 | $2,148 | $468.54 | 21.8% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 20 | 20 | $860.00 | $391.60 | 45.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 20 | 20 | $1,280 | $335.20 | 26.2% |
About Casey Sharp, NP
Casey Sharp, NP is a Family healthcare provider based in Danville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/27/2016. The National Provider Identifier (NPI) number assigned to this provider is 1063961472.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Casey Sharp, NP has received a total of $36,071 in payments from pharmaceutical and medical device companies, with $18,583 received in 2024. These payments were reported across 576 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($28,050).
As a Medicare-enrolled provider, Sharp has provided services to 1,069 Medicare beneficiaries, totaling 2,668 services with total Medicare billing of $128,186. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Danville, VA
- Active Since 09/27/2016
- Last Updated 07/20/2018
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1063961472
Products in Payments
- VRAYLAR (Drug) $29,540
- UBRELVY (Drug) $690.72
- INGREZZA (Drug) $666.92
- REXULTI (Drug) $540.12
- ABILIFY MAINTENA (Drug) $346.18
- ARISTADA (Drug) $291.21
- Azstarys (Drug) $270.14
- QELBREE (Drug) $254.52
- NURTEC ODT (Drug) $234.11
- QULIPTA (Drug) $227.67
- CAPLYTA (Drug) $184.80
- Auvelity (Drug) $177.67
- Rybelsus (Drug) $151.44
- FREESTYLE LIBRE 2 (Device) $149.96
- Aimovig (Biological) $139.84
- ABILIFY ASIMTUFII (Drug) $134.42
- Qelbree (Drug) $121.09
- Xelstrym (Drug) $106.48
- BRINTELLIX (Drug) $101.50
- Vascepa (Drug) $85.44
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Danville
Nancy Folley, Fnp, FNP
Family — Payments: $33,544
Family $33,544
Shahdi Vakili, F.n.p, F.N.P
Family — Payments: $27,125
Family $27,125
Phyllis Scarce, Fnp, Pnp, FNP, PNP
Family — Payments: $13,750
Family $13,750
Edythe Boitnott, Np, NP
Family — Payments: $9,544
Family $9,544
Michael Wagner, Fnp, FNP
Family — Payments: $8,114
Family $8,114
Mrs. Angela Thompson, Msn, Rn, Fnp-C, Cde, MSN, RN, FNP-C, CDE
Family — Payments: $7,337
Family $7,337